Dietary Fat Composition and Frailty in Oldest-Old Men by Jyväkorpi, Satu et al.
LETTERS TO THE EDITOR
RESEARCH
Dietary Fat Composition and Frailty in Oldest-Old Men
Several nutrition-related components, such as higher overall
diet quality, protein intake, and dietʼs antioxidant capacity,
have been inversely associated with frailty.1 However, an
important macronutrient, fat, has been less studied, espe-
cially in the oldest old. The results have also been con-
flicting: total fat intake has or has not been associated with
increased frailty risk,2,3 whereas monounsaturated fatty
acid (MUFA) intake was reported to be inversely associated
with frailty.4 Our hypothesis was that individual fatty acids
and fatty acids ratios may be linked with frailty because
cardiovascular disease is associated with increased risk of
frailty. Therefore, we explored relationships between frailty
and variables related to fat intake in oldest-old community-
living men.
METHODS
The Helsinki Businessmen Study (HBS) involves a socioeco-
nomically homogeneous cohort of men, born between 1919
and 1934, who have been followed since the 1960s.5 In the
present cross-sectional analysis, we report findings from the
most recent clinic visit including a random subcohort of home-
living survivors ofHBS in 2017-2018. At the visit, frailty status
was determined according tomodified Fried criteria as follows:
(1) weight loss more than 5% of body weight during the last
year; (2) low physical activity/exercise, explored with the ques-
tion “Do you exercise regularly?” (3) walking speed of .8 m/s
or slower, (4) handgrip strength less than 27 kg, and (5) self-
reported exhaustion, explored with the question “Have you
felt unusually tired or exhaustedmost of the time or all the time
during the last month?” Accordingly, participants were classi-
fied as robust (zero criteria fulfilled), pre-frail (one to two
criteria), and frail (at least three criteria).
Bodymass index (BMI) (in kg/m2) was calculated, and the
short form of theMini Nutritional Assessment (MNA-SF) per-
formed as instructed.6 Plasma lipid levels (total, low-density
lipoprotein [LDL]-cholesterol, and high-density lipoprotein
[HDL]-cholesterol; triglycerides), albumin, pre-albumin, and
high-sensitive C-reactive protein (hs-CRP) were analyzed after
a 12-hour fast, and the use of cholesterol-lowering medication
was recorded.
Dietary data including total fat intake and fat composition
of diet including saturated fatty acids (SFAs), MUFAs, and
polyunsaturated fatty acids (PUFAs), and vitamin E intakes
were analyzed from 3-day food diaries, and fat quality indica-
tors MUFA:SFA and PUFA:SFA ratios were calculated.
Because the food records are subject to misreporting, the par-
ticipants received both oral and written advice beforehand on
how to fill out the food records. After returning the food
records, the study nutritionist called the participants to con-
firm the dietary information and eaten amounts as accurately
as possible. Statistical significance of linearity was evaluated
for trend using analysis of variance for continuous variables
and the Cochran-Armitage test of categorical variables. Age
adjustment was not performed because frailty status was not
associated with age. Analyses were performed using the SPSS
statistical program, v.24 (IBMCorp, Armonk, NY, USA).
Ethics
The study protocol was approved by the ethics committee of
the Department ofMedicine at Helsinki University Hospital.
RESULTS
A random subsample of 180 survivors was invited to partici-
pate in the clinic visit. Of them, 130 participated in the visit
and 126 returned food diaries. The main reasons for refusal to
take part in the clinical examinations were poor health,
Alzheimerʼs disease, or hospitalization.
Of the participants, 31% (n = 40) we classified as robust,
54% (n = 70) as pre-frail, and 15% (n = 20) as frail. Age, BMI,
MNA-SF, or use of cholesterol-lowering statins did not differ
between frailty groups. Levels of total (P = .013), LDL-
cholesterol (P = .036), andHDL-cholesterol (P = .012), albumin
(P = .017), and pre-albumin (P = .044) were inversely associ-
ated, whereas hs-CRP (P = .012) was linearly associated with
frailty status (Table 1). Although total fat and SFA intakes were
not associated, there were inverse trends between frailty and
MUFA (P = .047) and PUFA (P = .044) intakes (Supplementary
Figure S1). Of fat quality indicators, the MUFA:SFA ratio
(P = .038) but not the PUFA:SFA ratio (P = .215) was inversely
associated with frailty. In addition, fat-soluble vitamin E intake
was inversely associatedwith frailty (P = .017).
DISCUSSION
Our study is one of the very few studies to explore detailed die-
tary fat composition and quality in relation to frailty pheno-
type, and significant associations were found in oldest-old
home-living men. Fatty acids participate in multiple functions
and interact with other dietary components as well as micro-
biome in the body, and thus dietary fat composition may be
either pro- or anti-inflammatory.7,8 Higher PUFA-containing
fats are a rich source of fat-soluble antioxidant vitamin E,
whose intake was previously associated with less frailty,9 asDOI: 10.1111/jgs.16402
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was also the case in our study. Frailty phenotypewas associated
with increased chronic inflammation,8 and in line with this,
hs-CRP was associated linearly with frailty status in our study.
Lowering of cholesterol, albumin, and pre-albumin levels are
further well-known associates with frailty, probably reflecting
both impaired liver function and inflammation.
The strengths of our study are the robust findings,
although the study sample was relatively small, and the fact
that to the best of our knowledge, this is the first study to
explore the relationship between fat quality and frailty. An
obvious limitation is that the surviving participants of HBS dif-
fer in many ways from the general population by being the
oldest-old men from the upper socioeconomic class. The cross-
sectional design of the study is a further limitation and prevents
drawing conclusions about causal relationships.
In conclusion, our study also supports prevailing dietary
guidelines10 about healthy dietary fat composition in the oldest
old. These findings should be corroborated in larger longitudi-
nal studies with different populations of older adults.
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Table 1. Macronutrient and Fat-Soluble Vitamin Intakes According to Frailty Status
Baseline characteristics and energy and nutrient intakes
Frailty status
Robust n = 40 Pre-frail n = 70 Frail n = 20 P valuea
Age, y (SD) 86.3 (2.6) 87.9 (3.0) 87.3 (2.9) .072
BMI, kg/m2 (SD) 25.6 (2.5) 26.0 (2.7) 25.6 (3.3) .842
MNA-SF (SD) 13.2 (1.0) 13.1 (1.3) 12.7 (1.5) .202
Use of statins, % 62.5 54.3 65.0 .934
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HDL-cholesterol, mmol/L (SD) 1.6 (.3) 1.4 (.3) 1.4 (.4) .012
Triglycerides, mmol/L (SD) 1.1 (.3) 1.2 (.4) 1.0 (.5) .807
hs-CRP (SD) 1.8 (2.2) 2.6 (3.0) 3.9 (4.4) .012
Albumin 38.7 (2.3) 37.6 (3.5) 36.8 (2.4) .017
Pre-albumin 250 (41) 247 (44) 222 (56) .044
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Fat, g 68 (23) 64 (20) 61 (21) .227
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MUFAs 27 (13) 24 (11) 21 (7) .047
PUFAs 13 (5) 12 (5) 11 (4) .044
PUFA:SFA ratio .64 (.2) .62 (.3) .53 (.2) .215
MUFA:SFA ratio 1.26 (.5) 1.15 (.4) 1.00 (.3) .038
Vitamin E, mg 12 (6) 10 (4) 9 (3) .017
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; hs-CRP, high-sensitive C-reactive protein; LDL, low-density lipoprotein; MNA, Mini
Nutritional Assessment; MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; SD, standard deviation; SFAs, saturated fatty acids.
aThe statistical significance of the hypotheses of linearity was evaluated for a trend using analysis of variance for continuous variables and the
Cochran-Armitage test for categorical variables; P value <.05 was considered statistically significant.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the
online version of this article.
Supplementary Figure S1: Intake of saturated fatty
acids (SFAs), monounsaturated fatty acids (MUFAs), and
polyunsaturated fatty acids (PUFAs) according to frailty
status.
COMMENT
Comment on: Objectively Measured Physical Activity
Reduces the Risk of Mortality Among Brazilian Older
Adults
To the Editor: In a recent issue of the journal, Bielemann
et al reported physical activity (PA) of any intensity, mea-
sured by accelerometry and questionnaire, was observed to
be a significant predictor of survival in community-dwelling
older individuals from southern Brazil.1 The use of an
accelerometer has been recommended to more objectively
rate the intensity of PA, but it had not been effectively
tested in a longitudinal study in the same population. Thus,
even though some differences across sexes were observed,
the results are considered significant, given the previous
scarce evidence of improvement in survival with light-
intensity PA in older people. However, we would be cautious
about reaching definite conclusions based on insufficiently
adjusted comparisons.
Among many predictors of risk of mortality, body mass
index (BMI) is strongly associated with life expectancy in older
adults.2 Either a lower (<22.5 kg/m2)3 or increased BMI4,5 was
shown to be associated with the risk of increased mortality in
these people. Besides, further weight gain can result in excess
mortality in obese individuals.6
The authors collected data of self-reported com-
orbidities at enrollment, which included high blood pres-
sure, diabetes, heart problems, heart failure, Parkinson’s
disease, kidney failure, hypercholesterolemia, depression,
stroke, and cancer. While people with such comorbidities
have varying degrees of limitations in PA, each of these
comorbidities influences survival rates differently in older
adults.7-10 Instead of focusing on diseases particularly
related to mortality, the authors chose to include a single
parameter as the total number of comorbidities in their
study. However, those who died during follow-up had
almost two-fold higher frequency of four or more morbid-
ities at baseline, suggesting some potential confounders
remained unnoticed in the analysis. Besides, effective treat-
ment of chronic conditions, such as hypertension, diabetes,
coronary heart disease, and hypercholesterolemia, as well
as the use of certain classes of drugs independently improve
survival, even in advanced ages. Finally, the residual impact
of some chronically used drugs, such as statins, in coronary
heart disease or certain antihyperglycemics in diabetes on
mortality outcome should not be disregarded in multivari-
able analyses.
Collectively, the results by Bielemann et al1 suggest
some evidence of improved overall survival by any intensity
of PA. However, to avoid significant confounding and pro-
vide more robust conclusions, future confirmatory studies
should include as many variables as possible that alter mor-
tality events in older populations.
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